Pages that link to "Q1438399"
Jump to navigation
Jump to search
The following pages link to Georges Mathé (Q1438399):
Displaying 50 items.
- Éliane Gluckman (Q3587692) (← links)
- (Q3103175) (redirect page) (← links)
- Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy (Q28328918) (← links)
- New experimental and clinical data on leukaemia immunotherapy (Q31440332) (← links)
- Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system (Q33272515) (← links)
- Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers (Q33336724) (← links)
- Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme (Q33361692) (← links)
- Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity (Q33396400) (← links)
- Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours (Q33451344) (← links)
- Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP). (Q33458954) (← links)
- Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE) (Q33465046) (← links)
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas (Q33465216) (← links)
- A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors) (Q33467346) (← links)
- The various aspects of the secondary syndrome complicating allogenic bone marrow transplantations or leukocyte transfusions in patients suffering from malignant hemopathies (Q33470107) (← links)
- Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU. (Q33482555) (← links)
- Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy (Q33653690) (← links)
- Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy (Q34346389) (← links)
- Attempts at stimulation of immune response in acute lymphod leukaemia (Q35141908) (← links)
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells (Q36038874) (← links)
- The two varieties of lymphoid tissue "reticulosarcomas", histiocytic and histioblastic types (Q36039659) (← links)
- Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy (Q36068365) (← links)
- Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers (Q36093083) (← links)
- Leukaemic conversion of non-Hodgkin's malignant lymphomata (Q36291027) (← links)
- Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV. (Q36291056) (← links)
- Results of radiotherapy in stages I and II of non-Hodgkin's lymphoma (Q36291140) (← links)
- Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia (Q36477505) (← links)
- [From hematology with microscope to hematology without microscope] (Q36518465) (← links)
- Of mice and men in bone marrow transplantation (Q36692491) (← links)
- Recent data on the immunotherapy of leukemias (Q36697178) (← links)
- Decreased microviscosity of membrane lipids in leukemic cells: Two possible mechanisms (Q37586312) (← links)
- Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy (Q38657538) (← links)
- Use of soluble histocompatibility antigen(s) in the control of transplantation reactions: possible dissociation of the roles of H-2 and non-H-2 antigens in the prevention of mortality induced by graft-versus-host reaction (Q39100931) (← links)
- Graft-versus-host reaction. Influence of genetic background in donor-recipient pairs incompatible for major histocompatibility complex (MHC) (Q39157308) (← links)
- AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipt (Q39229417) (← links)
- Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells (Q39242460) (← links)
- Lethal graft-versus-host reaction to minor histocompatibility antigens is decreased by donor immunization against H-2 and varies as a function of the H-2 haplotype (Q39254473) (← links)
- Letter:Intravenous B.C.G. in monkeys and man. (Q39362267) (← links)
- Letter: Immunotherapy for acute lymphoid leukemia (Q39362497) (← links)
- Letter: Remission induction in acute lymphoid and acute myeloid leukaemias (Q39378130) (← links)
- Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemias (Q39424346) (← links)
- Comparative study of the histologic reactions to intravenous injections of heat-killed Pseudomonas aeruginosa and of BCG (Q39711106) (← links)
- Clinical trials of the treatment of minimal residual tumours. (Q39739032) (← links)
- Further purification of the lymphocyte inhibiting extract from the thymus (Q39761841) (← links)
- Prevention and treatment of secondary disease--I. Effects of three non-specific agents: anti-thymocyte serum, antigen binding fragment extracted from anti-thymocyte serum and thymic chalone (Q39785289) (← links)
- Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results (Q39793856) (← links)
- Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines (Q39901792) (← links)
- Restoration of impaired immune functions of aged animals by chronic bestatin treatment (Q39902293) (← links)
- Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice (Q39908612) (← links)
- The immunological approach to cancer treatment. (Q40009022) (← links)
- Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors (Q40043780) (← links)